一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen(AKAO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-02-19 AccNo: 0001193125-19-044385 Size: 637 KB 网页链接
$Achaogen(AKAO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-15 AccNo: 0001535610-19-000070 Size: 13 KB 网页链接
$Achaogen(AKAO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-02-15 AccNo: 0001193125-19-041565 Size: 642 KB 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-02-14 AccNo: 0001193125-19-039480 Size: 50 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0001144204-19-007018 Size: 66 KB 网页链接
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0000093751-19-000037 Size: 8 KB 网页链接
$Achaogen(AKAO)$ 内部交易: 2019-02-05,Chief Commercial Officer,Dorling Janet ,卖出,818普通股, $1.35
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-10 AccNo: 0000215457-19-000102 Size: 12 KB 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-01-04 AccNo: 0001564590-19-000118 Size: 31 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$Achaogen, Inc.(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-12-12 AccNo: 0000921895-18-003281 Size: 133 KB 网页链接